RIL
KALV

Rothschild Investment LLC’s KalVista Pharmaceuticals KALV Stock Holding History

Rothschild Investment LLC’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-110
Closed -$2.21K – 3686
2026
Q1 		$2.21K Buy
110
+40
+57% +$645 ﹤0.01% 2510
2025
Q4 		$1.13K Sell
70
-50
-42% -$662 ﹤0.01% 2628
2025
Q3 		$1.46K Sell
120
-20
-14% -$276 ﹤0.01% 2412
2025
Q2 		$1.58K Buy
140
+35
+33% +$428 ﹤0.01% 2208
2025
Q1 		$1.21K Buy
105
+90
+600% +$919 ﹤0.01% 2227
2024
Q4 		$127 Sell
15
-25
-63% -$259 ﹤0.01% 2880
2024
Q3 		$463 Buy
40
+30
+300% +$377 ﹤0.01% 2491
2024
Q2 		$118 Buy
+10
New +$117 ﹤0.01% 2680

Other funds holding KALV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rothschild Investment LLC's KALV Position: Q2 2026 in Review

Rothschild Investment LLC sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 110 shares — an estimated $2.21K sold.

Rothschild Investment LLC first reported a position in KALV in Q2 2024 and held it in 8 quarters. The position peaked at $2.21K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

  • Rothschild Investment LLC reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Rothschild Investment LLC sold 110 KalVista Pharmaceuticals shares in Q2 2026, an estimated $2.21K.
  • Rothschild Investment LLC first reported a position in KalVista Pharmaceuticals in Q2 2024 and held it in 8 quarters.
  • Rothschild Investment LLC's KalVista Pharmaceuticals position peaked at $2.21K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.